Award-winning company, which offers a person-based data marketplace powered by blockchain, hires experienced market research sales professional
Measure Protocol, the ethical person-based data marketplace powered by blockchain, has hired John McLaren as Vice President of Sales. A new position for the company, McLaren will drive global sales, strategic partnerships and help to continue Measure’s growth trajectory. He will apply his decades of experience in the market research and consumer insights space to help share Measure’s vision, including its new solutions for behavioural data collection in a permission-based, blockchain-powered ecosystem.
Marketing Technology News: VOXOX Launches The Comeback Small Business Radio Show
“John brings a wealth of commercial experience to our team and his expertise will help drive us forward to meet our growth and partnership goals,” said Owen Hanks, CEO of Measure Protocol. “In today’s ecosystem, all industries are seeing the need for better ways to connect with their audiences. John will be instrumental in sharing Measure’s vision for creating a transparent, ethical marketplace that fosters deeper understanding of consumer opinions and attitudes.”
Marketing Technology News: Qualtrics and Korn Ferry Announce Significant Expansion of Strategic Partnership
McLaren comes to Measure with a diverse work background and nearly 30 years of experience leading market research industry sales teams. Most recently, he served in Vice President roles at SimilarWeb and Verto Analytics. Prior to this, he spent more than a decade as a VP at comScore. He started out his career at Giga Information Group/Forrester Research, ending a nine year stint there as Senior Director of Sales. He holds a degree from Santa Clara University, and will be based in the San Francisco Bay Area.
McLaren said, “I could not be more excited to join a team of such experienced market research professionals to help shape the future of our offering and guide our commercial efforts.”
Marketing Technology News: Sage X3 V2020 R2 Released in India to Enable Indian Pharma Companies
